-
Je něco špatně v tomto záznamu ?
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Y. Handelsman, JE. Anderson, GL. Bakris, CM. Ballantyne, DL. Bhatt, ZT. Bloomgarden, B. Bozkurt, MJ. Budoff, J. Butler, DZI. Cherney, RA. DeFronzo, S. Del Prato, RH. Eckel, G. Filippatos, GC. Fonarow, VA. Fonseca, WT. Garvey, F. Giorgino, PJ....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi
- MeSH
- diabetes mellitus 2. typu terapie MeSH
- lidé MeSH
- metabolické nemoci * terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), dyslipidemias, hypertension, and associated comorbidities such as pulmonary diseases and metabolism dysfunction-associated steatotic liver disease and metabolism dysfunction-associated steatohepatitis (MASLD and MASH, respectively, formerly known as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [NAFLD and NASH]). Because cardiorenal and metabolic diseases share pathophysiologic pathways, two or more are often present in the same individual. Findings from recent outcome trials have demonstrated benefits of various treatments across a range of conditions, suggesting a need for practice recommendations that will guide clinicians to better manage complex conditions involving diabetes, cardiorenal, and/or metabolic (DCRM) diseases. To meet this need, we formed an international volunteer task force comprising leading cardiologists, nephrologists, endocrinologists, and primary care physicians to develop the DCRM 2.0 Practice Recommendations, an updated and expanded revision of a previously published multispecialty consensus on the comprehensive management of persons living with DCRM. The recommendations are presented as 22 separate graphics covering the essentials of management to improve general health, control cardiorenal risk factors, and manage cardiorenal and metabolic comorbidities, leading to improved patient outcomes.
AdventHealth Translational Research Institute Orlando FL USA
Charles University Prague Czech Republic
David Geffen School of Medicine UCLA Los Angeles CA USA
Department of Cardiology National and Kapodistrian University of Athens Athens Greece
Department of Diabetes Central Clinical School Monash University Melbourne Australia
Department of Endocrinology Katholieke Universiteit Leuven Leuven Belgium
Department of Internal Medicine Icahn School of Medicine at Mount Sinai NY New York USA
Department of Medicine Baylor College of Medicine Houston TX USA
Department of Medicine Baylor College of Medicine Texas Heart Institute Houston TX USA
Department of Medicine Duke University Medical Center Durham NC USA
Division of Cardiology Duke University School of Medicine Durham NC USA
Division of Cardiology Johns Hopkins University School of Medicine Baltimore MD USA
Division of Endocrinology Metabolism and Nutrition Duke University School of Medicine Durham NC USA
Emory University Atlanta GA USA
Grunberger Diabetes Institute Bloomfield Hills MI USA
Hacettepe University Ankara Turkey
Harvard Medical School Boston University School of Medicine Boston MA USA
Harvard Medical School Brigham and Women's Hospital Boston MA USA
Imperial College London London United Kingdom
Interdisciplinary Research Center Health Science Sant'Anna School of Advanced Studies Pisa Italy
Metabolic Institute of America Tarzana CA USA
Mount Sinai Fuster Heart Hospital Icahn School of Medicine at Mount Sinai NY New York USA
Munich Diabetes Research Group e 5 at Helmholtz Centre Munich Germany
Oakland University William Beaumont School of Medicine Rochester MI USA
Polyclinique d'Aubervilliers Aubervilliers and Paris Nord University Paris France
Saint Luke's Mid America Heart Institute University of Missouri Kansas City Kansas City MO USA
St Michael's Hospital University of Toronto Toronto Canada
The Frist Clinic Nashville TN USA
Tulane University Health Sciences Center New Orleans LA USA
Université Paris Cité Institut Universitaire de France AP HP Hôpital Bichat Cardiology Paris France
University of Alabama at Birmingham Birmingham AL USA
University of California at Irvine Irvine CA USA
University of California San Diego School of Medicine La Jolla CA USA
University of Chicago Medicine Chicago IL USA
University of Colorado Anschutz Medical Campus Aurora CO USA
University of Copenhagen Copenhagen Denmark
University of Glasgow Glasgow United Kingdom
University of Helsinki Finnish Institute for Health and Welfare Helsinki Finland
University of Leeds Leeds United Kingdom
University of Leicester Leicester United Kingdom
University of Liverpool Liverpool United Kingdom
University of Mississippi Medical Center Jackson MS USA
University of Texas Health Science Center San Antonio TX USA
Washington University School of Medicine Saint Louis MO USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018810
- 003
- CZ-PrNML
- 005
- 20241024111311.0
- 007
- ta
- 008
- 241015e20240607xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.metabol.2024.155931 $2 doi
- 035 __
- $a (PubMed)38852020
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Handelsman, Yehuda $u Metabolic Institute of America, Tarzana, CA, USA. Electronic address: yhandelsman@gmail.com
- 245 10
- $a DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases / $c Y. Handelsman, JE. Anderson, GL. Bakris, CM. Ballantyne, DL. Bhatt, ZT. Bloomgarden, B. Bozkurt, MJ. Budoff, J. Butler, DZI. Cherney, RA. DeFronzo, S. Del Prato, RH. Eckel, G. Filippatos, GC. Fonarow, VA. Fonseca, WT. Garvey, F. Giorgino, PJ. Grant, JB. Green, SJ. Greene, PH. Groop, G. Grunberger, AM. Jastreboff, PS. Jellinger, K. Khunti, S. Klein, MN. Kosiborod, P. Kushner, LA. Leiter, NE. Lepor, CS. Mantzoros, C. Mathieu, CW. Mende, ED. Michos, J. Morales, J. Plutzky, RE. Pratley, KK. Ray, P. Rossing, N. Sattar, PEH. Schwarz, E. Standl, PG. Steg, L. Tokgözoğlu, J. Tuomilehto, GE. Umpierrez, P. Valensi, MR. Weir, J. Wilding, EE. Wright
- 520 9_
- $a The spectrum of cardiorenal and metabolic diseases comprises many disorders, including obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), dyslipidemias, hypertension, and associated comorbidities such as pulmonary diseases and metabolism dysfunction-associated steatotic liver disease and metabolism dysfunction-associated steatohepatitis (MASLD and MASH, respectively, formerly known as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [NAFLD and NASH]). Because cardiorenal and metabolic diseases share pathophysiologic pathways, two or more are often present in the same individual. Findings from recent outcome trials have demonstrated benefits of various treatments across a range of conditions, suggesting a need for practice recommendations that will guide clinicians to better manage complex conditions involving diabetes, cardiorenal, and/or metabolic (DCRM) diseases. To meet this need, we formed an international volunteer task force comprising leading cardiologists, nephrologists, endocrinologists, and primary care physicians to develop the DCRM 2.0 Practice Recommendations, an updated and expanded revision of a previously published multispecialty consensus on the comprehensive management of persons living with DCRM. The recommendations are presented as 22 separate graphics covering the essentials of management to improve general health, control cardiorenal risk factors, and manage cardiorenal and metabolic comorbidities, leading to improved patient outcomes.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a diabetes mellitus 2. typu $x terapie $7 D003924
- 650 12
- $a metabolické nemoci $x terapie $7 D008659
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Anderson, John E $u The Frist Clinic, Nashville, TN, USA
- 700 1_
- $a Bakris, George L $u University of Chicago Medicine, Chicago, IL, USA
- 700 1_
- $a Ballantyne, Christie M $u Department of Medicine, Baylor College of Medicine, Texas Heart Institute, Houston, TX, USA
- 700 1_
- $a Bhatt, Deepak L $u Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, NY, New York, USA
- 700 1_
- $a Bloomgarden, Zachary T $u Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, NY, New York, USA
- 700 1_
- $a Bozkurt, Biykem $u Department of Medicine, Baylor College of Medicine, Houston, TX, USA
- 700 1_
- $a Budoff, Matthew J $u David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
- 700 1_
- $a Butler, Javed $u University of Mississippi Medical Center, Jackson, MS, USA
- 700 1_
- $a Cherney, David Z I $u Division of Nephrology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada
- 700 1_
- $a DeFronzo, Ralph A $u University of Texas Health Science Center, San Antonio, TX, USA
- 700 1_
- $a Del Prato, Stefano $u Interdisciplinary Research Center "Health Science", Sant'Anna School of Advanced Studies, Pisa, Italy
- 700 1_
- $a Eckel, Robert H $u University of Colorado Anschutz Medical Campus, Aurora, CO, USA
- 700 1_
- $a Filippatos, Gerasimos $u Department of Cardiology, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Fonarow, Gregg C $u David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
- 700 1_
- $a Fonseca, Vivian A $u Tulane University Health Sciences Center, New Orleans, LA, USA
- 700 1_
- $a Garvey, W Timothy $u University of Alabama at Birmingham, Birmingham, AL, USA
- 700 1_
- $a Giorgino, Francesco $u Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy
- 700 1_
- $a Grant, Peter J $u University of Leeds, Leeds, United Kingdom
- 700 1_
- $a Green, Jennifer B $u Division of Endocrinology, Metabolism, and Nutrition, Duke University School of Medicine, Durham, NC, USA
- 700 1_
- $a Greene, Stephen J $u Division of Cardiology, Duke University School of Medicine, Durham, NC, USA
- 700 1_
- $a Groop, Per-Henrik $u Department of Nephrology, University of Helsinki, Finnish Institute for Health and Helsinki University HospitalWelfare, Folkhälsan Research Center, Helsinki, Finland; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia
- 700 1_
- $a Grunberger, George $u Grunberger Diabetes Institute, Bloomfield Hills, MI, USA; Wayne State University School of Medicine, Detroit, MI, USA; Oakland University William Beaumont School of Medicine, Rochester, MI, USA; Charles University, Prague, Czech Republic
- 700 1_
- $a Jastreboff, Ania M $u Yale University School of Medicine, New Haven, CT, USA
- 700 1_
- $a Jellinger, Paul S $u The Center for Diabetes & Endocrine Care, University of Miami Miller School of Medicine, Hollywood, FL, USA
- 700 1_
- $a Khunti, Kamlesh $u University of Leicester, Leicester, United Kingdom
- 700 1_
- $a Klein, Samuel $u Washington University School of Medicine, Saint Louis, MO, USA
- 700 1_
- $a Kosiborod, Mikhail N $u Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA
- 700 1_
- $a Kushner, Pamela $u University of California at Irvine, Irvine, CA, USA
- 700 1_
- $a Leiter, Lawrence A $u St. Michael's Hospital, University of Toronto, Toronto, Canada
- 700 1_
- $a Lepor, Norman E $u David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
- 700 1_
- $a Mantzoros, Christos S $u Harvard Medical School, Boston University School of Medicine, Boston, MA, USA
- 700 1_
- $a Mathieu, Chantal $u Department of Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium
- 700 1_
- $a Mende, Christian W $u University of California San Diego School of Medicine, La Jolla, CA, USA
- 700 1_
- $a Michos, Erin D $u Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 700 1_
- $a Morales, Javier $u Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, Advanced Internal Medicine Group, PC, East Hills, NY, USA
- 700 1_
- $a Plutzky, Jorge $u Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA
- 700 1_
- $a Pratley, Richard E $u AdventHealth Translational Research Institute, Orlando, FL, USA
- 700 1_
- $a Ray, Kausik K $u Imperial College London, London, United Kingdom
- 700 1_
- $a Rossing, Peter $u University of Copenhagen, Copenhagen, Denmark
- 700 1_
- $a Sattar, Naveed $u University of Glasgow, Glasgow, United Kingdom
- 700 1_
- $a Schwarz, Peter E H $u Department for Prevention and Care of Diabetes, Faculty of Medicine Carl Gustav Carus at the Technische Universität/TU Dresden, Dresden, Germany
- 700 1_
- $a Standl, Eberhard $u Munich Diabetes Research Group e.V. at Helmholtz Centre, Munich, Germany
- 700 1_
- $a Steg, P Gabriel $u Université Paris-Cité, Institut Universitaire de France, AP-HP, Hôpital Bichat, Cardiology, Paris, France
- 700 1_
- $a Tokgözoğlu, Lale $u Hacettepe University, Ankara, Turkey
- 700 1_
- $a Tuomilehto, Jaakko $u University of Helsinki, Finnish Institute for Health and Welfare, Helsinki, Finland
- 700 1_
- $a Umpierrez, Guillermo E $u Emory University, Atlanta, GA, USA
- 700 1_
- $a Valensi, Paul $u Polyclinique d'Aubervilliers, Aubervilliers and Paris-Nord University, Paris, France
- 700 1_
- $a Weir, Matthew R $u Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
- 700 1_
- $a Wilding, John $u University of Liverpool, Liverpool, United Kingdom
- 700 1_
- $a Wright, Eugene E $u Department of Medicine, Duke University Medical Center, Durham, NC, USA
- 773 0_
- $w MED00010225 $t Metabolism: clinical and experimental $x 1532-8600 $g Roč. 159 (20240607), s. 155931
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38852020 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111304 $b ABA008
- 999 __
- $a ok $b bmc $g 2201581 $s 1230783
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 159 $c - $d 155931 $e 20240607 $i 1532-8600 $m Metabolism: clinical and experimental $n Metabolism $x MED00010225
- LZP __
- $a Pubmed-20241015
